Found: 14
Select item for more details and to access through your institution.
Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00595-0
- By:
- Publication type:
- Article
SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00594-1
- By:
- Publication type:
- Article
"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00592-3
- By:
- Publication type:
- Article
Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00591-4
- By:
- Publication type:
- Article
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00589-y
- By:
- Publication type:
- Article
Impact of COVID-19 in patients with multiple myeloma based on a global data network.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00588-z
- By:
- Publication type:
- Article
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00587-0
- By:
- Publication type:
- Article
Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00586-1
- By:
- Publication type:
- Article
Differentiation therapy for myeloid malignancies: beyond cytotoxicity.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00584-3
- By:
- Publication type:
- Article
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00581-6
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00580-7
- By:
- Publication type:
- Article
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CT.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00577-2
- By:
- Publication type:
- Article